2007 Neurofibromatosis Conference

描述（由申请人提供）：本申请要求为儿童肿瘤基金会国际NF会议2007年年会提供资金支持。会议将于2007年6月10日至12日在犹他州帕克城的塞隆斯度假村举行。自1985年成立以来，该年会已经取得了丰硕的成果，它作为NF社区研究人员和临床医生的首要年度聚会发挥着关键作用。该会议是一个为来自世界各地的研究人员提供研究信息交流和讨论的论坛，传统上促进了合作，建立共识，并在临床试验中达到顶峰的转化研究的进展。这是NF研究在许多方面取得巨大进展的时代，从基础到临床，这反映在2007年会议的主题-“模型，机制和治疗靶点”中。七个单独的会议将采取从NF的分子机制，通过翻译模型的临床治疗的联盟。演讲者将包括初级和高级研究人员。本次会议的目的是并列目前的研究结果在生化，细胞和有机体系统与临床前和临床研究。每一次会议还将包括一个主要的研究人员从NF研究以外的主题演讲，开辟了广泛的讨论。有竞争力的旅行奖将带来年轻的研究人员进行口头介绍，两个海报会议将允许研究人员介绍他们的工作，以NF社区。我们已经采取了两种新的方法，以增加本次会议的知名度和NF研究的状态。首先，为了提高业界对NF的认识，我们将寻求大量制药公司的财政赞助。奖励奖金将提供钻石，白金，黄金和银的水平。第二，共同主席和基金会将共同努力，争取在同行评审的期刊上发表一份联合会报告。这将促进整个研究界的NF研究的地位，与其他癌症和神经系统疾病的联系以及需要解决的关键障碍。

DESCRIPTION (provided by applicant): This application requests funding support for the 2007 annual meeting of the Children's Tumor Foundation International NF Conference. The Meeting will be held June 10-12, 2007, at the Canyons Resort in Park City, Utah. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts, from basic through clinical, and this is reflected in the theme of the 2007 meeting - 'Models, Mechanisms, and Therapeutic Targets'. Seven individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. The goal of this meeting is to juxtapose current findings in biochemical, cellular and organismal systems with preclinical and clinical studies. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and two poster sessions will allow investigators to present their work to the NF community. We have taken two new approaches in order to increase the visibility of this meeting and of the state of NF research. First, to increase industry awareness of NF, we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co- chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.